AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21883125 — intervention group
Group type: COMPARATOR
Intervention: Codeine group (codeine 1.5 mg.kg(‐1))
Number of subjects: 65
Study 19210151 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine/valsartan 5/320 mg once daily (o.d.)
Number of subjects: 403
Study 19210151 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine/valsartan 2.5/160 mg o.d. (initial treatment)
Number of subjects: 403
Study 19210151 — intervention group
Group type: COMPARATOR
Intervention: Placebo, amlodipine, valsartan, or combination therapy (core study)
Number of subjects: 403
Study 16632278 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries 1 or 2 filters for periapical images
Number of subjects: 20
Study 16632278 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal 1 or 2 filters for panoramic images
Number of subjects: 20
Study 16632278 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiographs
Number of subjects: 20
Study 16632278 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonfiltered and Noise Reduction-filtered images
Number of subjects: 20
Study 15509930 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified mattress suture technique
Number of subjects: 50
Study 15509930 — intervention group
Group type: COMPARATOR
Intervention: Hinderer technique
Number of subjects: 50
Study 11729578 — intervention group
Group type: EXPERIMENTAL
Intervention: Dead Sea bath salt
Number of subjects: 23
Study 11729578 — intervention group
Group type: COMPARATOR
Intervention: Common salt
Number of subjects: 23
Study 9270664 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) 2 g/kg
Number of subjects: 46
Study 9270664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 7525790 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with hyperthermia (group B)
Number of subjects: 40
Study 7525790 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (group A)
Number of subjects: 40
Study 7525790 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with hyperthermia (group B) excluding T1 tumours
Number of subjects: 40
Study 7525790 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (group A) excluding T1 tumours
Number of subjects: 40
Study 3669679 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstain from drinking for 2 weeks
Number of subjects: 170
Study 3669679 — intervention group
Group type: COMPARATOR
Intervention: Maintain usual drinking patterns for 2 weeks
Number of subjects: 170
Study 29757758 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided pulsed radiofrequency (PRF) at 42°C for 120 seconds
Number of subjects: 0
Study 29757758 — intervention group
Group type: COMPARATOR
Intervention: Sham group (mimicking PRF)
Number of subjects: 0
Study 28034308 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin-C (MMC)
Number of subjects: 94
Study 28034308 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen Matrix (CM)
Number of subjects: 94
Study 23909480 — intervention group
Group type: EXPERIMENTAL
Intervention: 450 IU recombinant FSH (cycle 2)
Number of subjects: 10
Study 23909480 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (cycle 1)
Number of subjects: 10
Study 21910559 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 48
Study 21910559 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmindfulness stress reduction (NMSR)
Number of subjects: 48
Study 21910559 — intervention group
Group type: COMPARATOR
Intervention: Inactive control group (financial incentive)
Number of subjects: 48
Study 21910559 — intervention group
Group type: COMPARATOR
Intervention: Inactive control group (nonincentive)
Number of subjects: 48
Study 20352546 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized feedback intervention
Number of subjects: 0
Study 20352546 — intervention group
Group type: COMPARATOR
Intervention: Standard information (control)
Number of subjects: 0
Study 17913583 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH)
Number of subjects: 530
Study 17913583 — intervention group
Group type: COMPARATOR
Intervention: No unfractionated heparin (no UFH)
Number of subjects: 530
Study 17913583 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population (UFH and no UFH)
Number of subjects: 530
Study 16207788 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta oscillations gated by a working-memory task in occipital/parietal cortex (45/157 sites)
Number of subjects: 10
Study 16207788 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta oscillations gated by a working-memory task in temporal cortex (23/280 sites)
Number of subjects: 10
Study 16207788 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta oscillations in frontal cortex (2/182 sites)
Number of subjects: 10
Study 16207788 — intervention group
Group type: EXPERIMENTAL
Intervention: Coherence measures of nearby gated sites (<20 mm)
Number of subjects: 10
Study 16207788 — intervention group
Group type: EXPERIMENTAL
Intervention: Coherence measures of distant gated sites
Number of subjects: 10
Study 14609161 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic-impregnated shunt (AIS) system
Number of subjects: 110
Study 14609161 — intervention group
Group type: COMPARATOR
Intervention: Control shunt system
Number of subjects: 110
Study 11016157 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascoril cough formula
Number of subjects: 50
Study 11016157 — intervention group
Group type: COMPARATOR
Intervention: Other cough formula
Number of subjects: 50
Study 8845887 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital replacement mattress
Number of subjects: 23
Study 8845887 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital mattress
Number of subjects: 23
Study 1342258 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum cholesterol levels in women under age 65
Number of subjects: 5455
Study 1342258 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum cholesterol levels in older hypertensive women
Number of subjects: 5455
Study 1342258 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum cholesterol levels in younger and older hypertensive men
Number of subjects: 5455
Study 6233548 — intervention group
Group type: EXPERIMENTAL
Intervention: Duovent
Number of subjects: 16
Study 6233548 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 16
Study 30540568 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline
Number of subjects: 116
Study 30540568 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention (Control)
Number of subjects: 116
Study 29481507 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized digital guiding plate-assisted radiofrequency
Number of subjects: 93
Study 29481507 — intervention group
Group type: COMPARATOR
Intervention: Traditional method
Number of subjects: 93
Study 27490915 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 30
Study 27490915 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 25675568 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture therapy at three nasal points (Yingxiang, Yintang, Bitong) and syndrome differentiation
Number of subjects: 60
Study 25675568 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of loratadine, 10 mg daily for 4 weeks
Number of subjects: 60
Study 25675568 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture therapy
Number of subjects: 60
Study 25675568 — intervention group
Group type: COMPARATOR
Intervention: Loratadine
Number of subjects: 60
Study 22988126 — intervention group
Group type: EXPERIMENTAL
Intervention: Male applicant
Number of subjects: 127
Study 22988126 — intervention group
Group type: COMPARATOR
Intervention: Female applicant
Number of subjects: 127
Study 22988126 — intervention group
Group type: EXPERIMENTAL
Intervention: Preexisting subtle bias against women
Number of subjects: 127
Study 20522355 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca block
Number of subjects: 23
Study 20522355 — intervention group
Group type: COMPARATOR
Intervention: Femoral nerve block
Number of subjects: 23
Study 18628422 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month moderate-to-vigorous aerobic exercise intervention (6 days/week, 60 minutes/day, 60-85% maximum heart rate)
Number of subjects: 202
Study 18628422 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 202
Study 16042036 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's disease and depression (AD + D)
Number of subjects: 301
Study 16042036 — intervention group
Group type: COMPARATOR
Intervention: Alzheimer's disease without depression (AD - D)
Number of subjects: 301
Study 16042036 — intervention group
Group type: COMPARATOR
Intervention: Normal older adults
Number of subjects: 301
Study 16042036 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 301
Study 12503784 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavelet-based fractal analysis method
Number of subjects: 23
Study 10348228 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel treatment
Number of subjects: 181
Study 7805930 — intervention group
Group type: EXPERIMENTAL
Intervention: DMSO
Number of subjects: 488
Study 7805930 — intervention group
Group type: COMPARATOR
Intervention: 1,2-propanediol
Number of subjects: 488
Study 7805930 — intervention group
Group type: COMPARATOR
Intervention: DMSO and 1,2-propanediol
Number of subjects: 488
Study 1931536 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose (15 ml bd, increasing to 60 ml daily if necessary)
Number of subjects: 124
Study 1931536 — intervention group
Group type: COMPARATOR
Intervention: Ispaghula (one sachet bd)
Number of subjects: 124
Study 6804082 — intervention group
Group type: EXPERIMENTAL
Intervention: Methanol extraction residue of Bacillus Calmette-Guerin (MER/BCG)
Number of subjects: 196
Study 6804082 — intervention group
Group type: COMPARATOR
Intervention: No immunotherapy (Control)
Number of subjects: 196
Study 31695344 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking (NW)
Number of subjects: 38
Study 31695344 — intervention group
Group type: COMPARATOR
Intervention: Walking (W)
Number of subjects: 38
Study 29783024 — intervention group
Group type: EXPERIMENTAL
Intervention: Iclaprim 80 mg intravenously every 12 h for 5-14 days
Number of subjects: 1200
Study 29783024 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin 15 mg/kg intravenously every 12 h for 5-14 days
Number of subjects: 1200
Study 29783024 — intervention group
Group type: EXPERIMENTAL
Intervention: Iclaprim
Number of subjects: 1200
Study 29783024 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 1200
Study 26817490 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon-heated tobacco product (CHTP)
Number of subjects: 112
Study 26817490 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking abstinence (SA)
Number of subjects: 112
Study 26817490 — intervention group
Group type: COMPARATOR
Intervention: Combustible cigarettes (CCs)
Number of subjects: 112
Study 25230154 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg baclofen
Number of subjects: 24
Study 25230154 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 22721632 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (IMN) 2 40-mg tablets
Number of subjects: 200
Study 22721632 — intervention group
Group type: COMPARATOR
Intervention: Pyridoxine (placebo) 2 40-mg tablets
Number of subjects: 200
Study 20585761 — intervention group
Group type: EXPERIMENTAL
Intervention: Food and nicotine deprivation (12 h food deprivation, 18 h nicotine deprivation)
Number of subjects: 30
Study 20585761 — intervention group
Group type: COMPARATOR
Intervention: Nicotine deprivation only (18 h nicotine deprivation)
Number of subjects: 30
Study 17106061 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (45 mg/day)
Number of subjects: 64
Study 17106061 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (8 mg/day)
Number of subjects: 64
Study 17106061 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 17106061 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone + drug-naïve diabetics
Number of subjects: 64
Study 17106061 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone + sulfonylurea-treated diabetics
Number of subjects: 64
Study 17106061 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone + sulfonylurea-withdrawn diabetics
Number of subjects: 64
Study 15646603 — intervention group
Group type: EXPERIMENTAL
Intervention: Academic detailing program
Number of subjects: 88
Study 15646603 — intervention group
Group type: COMPARATOR
Intervention: Practice as usual
Number of subjects: 88
Study 11306159 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium restorations
Number of subjects: 110
Study 11306159 — intervention group
Group type: COMPARATOR
Intervention: High gold alloy restorations
Number of subjects: 110
Study 9704685 — intervention group
Group type: EXPERIMENTAL
Intervention: 1994 treatment (aspirin, ACE inhibitors, beta-blockers, nitrates, thrombolytic therapy, coronary angiography, PTCA, CABG)
Number of subjects: 835
Study 9704685 — intervention group
Group type: EXPERIMENTAL
Intervention: 1994 cohort
Number of subjects: 835
Study 8046740 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentamidine therapy
Number of subjects: 56
Study 3291088 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Expiratory Pressure (PEP)
Number of subjects: 8
Study 3291088 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced Expiration Technique (FET)
Number of subjects: 8
Study 3291088 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 8
Study 30413312 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat-based complementary diet
Number of subjects: 53
Study 30413312 — intervention group
Group type: COMPARATOR
Intervention: Dairy-based complementary diet
Number of subjects: 53
Study 30413312 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study 28838379 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaratumab + Paclitaxel/Carboplatin (P/C)
Number of subjects: 131
Study 28838379 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel/Carboplatin (P/C) alone
Number of subjects: 131
Study 25113275 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1Hz rTMS applied at the onset of training movements
Number of subjects: 0
Study 25113275 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 0
Study 23813295 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone + CBT
Number of subjects: 243
Study 23813295 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate + CBT
Number of subjects: 243
Study 23813295 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram + CBT
Number of subjects: 243
Study 23813295 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 243
Study 22054050 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (300-800 mg/d)
Number of subjects: 1226
Study 22054050 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium (0.6-1.2 mEq/L)
Number of subjects: 1226
Study 22054050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1226
Study 19794987 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihistamine (2 mL, 45.5 mg pheniramine maleate)
Number of subjects: 171
Study 19794987 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (2 mL)
Number of subjects: 171
Study 14745084 — intervention group
Group type: EXPERIMENTAL
Intervention: CEP-1347
Number of subjects: 30
Study 10520808 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise training (supervised walking three times a week for 16 weeks at 40% to 70% of peak oxygen uptake)
Number of subjects: 19
Study 10520808 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 19
Study 7737444 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical assistant telephone call
Number of subjects: 151
Study 7737444 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician telephone call
Number of subjects: 151
Study 7737444 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 151
Study 7737444 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response for widows
Number of subjects: 151
Study 7737444 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response for other marital groups
Number of subjects: 151
Study 7737444 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost per intervention for physician telephone call
Number of subjects: 151
Study 7737444 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost per intervention for physician letter
Number of subjects: 151
Study 7737444 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost per intervention for medical assistant call
Number of subjects: 151
Study 1704245 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help materials (audiotape and booklet) in addition to current treatment
Number of subjects: 0
Study 1704245 — intervention group
Group type: COMPARATOR
Intervention: Control group (current treatment only)
Number of subjects: 0
Study 7286031 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of diacetolol 100 mg
Number of subjects: 6
Study 7286031 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of diacetolol 100 mg
Number of subjects: 6
Study 7286031 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of diacetolol 400 mg
Number of subjects: 6
Study 7286031 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of diacetolol 800 mg
Number of subjects: 6
Study 30670036 — intervention group
Group type: COMPARATOR
Intervention: Pedometer-based walking intervention (postal)
Number of subjects: 1023
Study 30670036 — intervention group
Group type: COMPARATOR
Intervention: Pedometer-based walking intervention (nurse support)
Number of subjects: 1023
Study 30206192 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye-health program based on social learning theory (EPST) including eye-health education and eye exercises
Number of subjects: 141
Study 30206192 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 141
Study 26773246 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbetocin (100mcg intravenous bolus)
Number of subjects: 547
Study 26773246 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin (10IU intravenous bolus)
Number of subjects: 547
Study 26773246 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbetocin
Number of subjects: 547
Study 26773246 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 547
Study 25157951 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release oxycodone/acetaminophen (ER OC/APAP) 15/650 mg total dose, two tablets every 12 hours for ≤ 14 days
Number of subjects: 146
Study 25157951 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release oxycodone/acetaminophen (ER OC/APAP)
Number of subjects: 146
Study 21811833 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib 400 mg crushed tablet
Number of subjects: 0
Study 21811833 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib 400 mg oral suspension
Number of subjects: 0
Study 21811833 — intervention group
Group type: COMPARATOR
Intervention: Whole tablet administration
Number of subjects: 0
Study 19410947 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IQ IOL
Number of subjects: 524
Study 19410947 — intervention group
Group type: COMPARATOR
Intervention: AcrySof SN60AT IOL
Number of subjects: 524
Study 17467954 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolactin-sparing anti-psychotics (e.g., olanzapine) with specific interventions (n=8)
Number of subjects: 38
Study 17467954 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolactin-raising anti-psychotics with specific interventions (n=8)
Number of subjects: 38
Study 17467954 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolactin-sparing anti-psychotics with no specific interventions (n=5)
Number of subjects: 38
Study 17467954 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolactin-raising anti-psychotics with no specific interventions (n=20)
Number of subjects: 38
Study 15681525 — intervention group
Group type: COMPARATOR
Intervention: bicalutamide (150 mg/d) plus placebo
Number of subjects: 114
Study 15681525 — intervention group
Group type: EXPERIMENTAL
Intervention: bicalutamide (150 mg/d) plus tamoxifen (20 mg/d)
Number of subjects: 114
Study 15681525 — intervention group
Group type: EXPERIMENTAL
Intervention: bicalutamide (150 mg/d) plus anastrozole (1 mg/d)
Number of subjects: 114
Study 11888875 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritumoral (PT) injection of blue dye
Number of subjects: 332
Study 11888875 — intervention group
Group type: EXPERIMENTAL
Intervention: Subareolar (SA) injection of blue dye
Number of subjects: 332
Study 9793614 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal administration of tramadol suppositories (100 mg)
Number of subjects: 10
Study 9793614 — intervention group
Group type: COMPARATOR
Intervention: Intravenous injection of tramadol (2 ml solution for injection, 100 mg)
Number of subjects: 10
Study 7547045 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 50
Study 7547045 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 50
Study 2505603 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-up period before exercise
Number of subjects: 33
Study 2505603 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual nitroglycerin (0.5 mg)
Number of subjects: 33
Study 2505603 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise during angiography
Number of subjects: 33
Study 31533741 — intervention group
Group type: EXPERIMENTAL
Intervention: Community based educational interventions targeting health providers and women in childbearing period
Number of subjects: 20494
Study 27441916 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia group
Number of subjects: 24
Study 27441916 — intervention group
Group type: COMPARATOR
Intervention: Normoxia group
Number of subjects: 24
Study 27441916 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24